Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
24.85
-0.58 (-2.28%)
Sep 1, 2026, 11:18 AM EDT - Market open
Dyne Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Buy Maintains $40 | Buy | Maintains | $40 | +60.97% | Aug 25, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $50 | Buy | Maintains | $50 | +101.21% | Aug 17, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jul 31, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $37 | Buy | Maintains | $37 | +48.89% | Jul 31, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $30 → $35 | Buy | Reiterates | $30 → $35 | +40.85% | Jul 30, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $47 | Buy | Reiterates | $47 | +89.13% | Jul 30, 2026 |
| Chardan Capital | Chardan Capital | Buy Maintains $38 | Buy | Maintains | $38 | +52.92% | Jul 30, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Reiterates $44 | Buy | Reiterates | $44 | +77.06% | Jul 29, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.